Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 12Phase 1/2 6Phase NA 3Phase 3 3Phase EARLY_PHASE1 2

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Breast Neoplasms 15Stomach Neoplasms 8Carcinoma, Hepatocellular 8Rectal Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Brain Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Recurrence 4Urinary Bladder Neoplasms 3Pilonidal Sinus 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Melanoma 3Lung Neoplasms 3Kidney Neoplasms 3Glioblastoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Pain, Postoperative 2Pain 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Liver Neoplasms 2Gastrointestinal Stromal Tumors 2

Interventions

Magnetic Resonance Spectroscopy 17Blood Specimen Collection 8Bevacizumab 8Temozolomide 7Radiotherapy 5Palliative Care 4Surgical Procedures, Operative 3Restraint, Physical 3Radiation 3Biopsy 3Yoga 2Standard of Care 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Psychosocial Intervention 2Perfusion Magnetic Resonance Imaging 2Mind-Body Therapies 2Magnetic Resonance Imaging 2Lomustine 2Gadolinium DTPA 2Elasticity Imaging Techniques 2Early Intervention, Educational 2Drug Therapy 2Diet Therapy 2Dexamethasone 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Glioblastoma × Surgical Procedures, Operative × Clear all
NCT01872221 2026-04-14

STEMRI

Institut Claudius Regaud

Phase NA Completed
21 enrolled
CNS

Glioblastoma

NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT01637753 2012-07-11

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase NA Unknown
212 enrolled
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡